1
Investors
About
NuVision Biotherapies develops innovative therapies for ocular surface disease, specializing in natural amniotic membrane-based wound dressings and grafting materials to promote rapid and accessible eye healing.
Explore NuVision Biotherapies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.